Mark L. Baum
Overview
Mark L. Baum received an average of $3M in total compensation, including $413K in salary, at Imprimis Pharmaceuticals from 2012 to 2022.
2022Imprimis PharmaceuticalsChief Executive Officer
2021Imprimis PharmaceuticalsChief Executive Officer
2020Imprimis PharmaceuticalsChief Executive Officer
2019Imprimis PharmaceuticalsChief Executive Officer
2018Imprimis PharmaceuticalsChief Executive Officer
2017Imprimis PharmaceuticalsChief Executive Officer
2016Imprimis PharmaceuticalsChief Executive Officer
2015Imprimis PharmaceuticalsChief Executive Officer
2014Imprimis PharmaceuticalsChief Executive Officer
2013Imprimis PharmaceuticalsChief Executive Officer
Source: SEC filings on April 28, 2023, April 26, 2022, April 23, 2021, April 24, 2020, April 25, 2019, April 30, 2018, April 27, 2017, April 10, 2015, and September 12, 2013.
Related executives
We found six more executives who work or worked at Imprimis Pharmaceuticals.
Andrew Boll
Imprimis Pharmaceuticals
Chief Financial Officer
John Saharek
Imprimis Pharmaceuticals
Chief Commercial Officer and President, ImprimisRx
Balbir Brar
Imprimis Pharmaceuticals
Former President
Joachim Schupp
Imprimis Pharmaceuticals
Chief Medical Officer
Juliet Singh
Imprimis Pharmaceuticals
Chief Executive Officer
John Lomoro
Imprimis Pharmaceuticals
Chief Financial Officer
News
Imprimis Pharmaceuticals CEO Mark Baum's 2022 pay falls 84% to $1.2M
April 28, 2023
Imprimis Pharmaceuticals CEO Mark Baum's 2021 pay jumps 195% to $7.3M
April 26, 2022
Imprimis Pharmaceuticals CEO Mark Baum's 2020 pay jumps 80% to $2.5M
April 23, 2021
Imprimis Pharmaceuticals CEO Mark Baum's 2019 pay jumps 30% to $1.4M
April 24, 2020
Imprimis Pharmaceuticals CEO Mark Baum's 2018 pay rises 16% to $1.1M
April 25, 2019